Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

West Pharmaceuticals, Inc Appoints New Vice President of Business Development for Drug Delivery Division

By Pharmaceutical Processing | November 4, 2003

West Pharmaceutical Services, Inc. (NYSE: WST)today announced that Jeffrey McGuire, Ph.D., has joined the company as Vice President of Business Development, Drug Delivery Division, North America.

In this new role, Dr. McGuire will be responsible for establishing collaborations and licenses with North American pharmaceutical and biotechnology companies for West’s Drug Delivery Division. Prior to joining West, Dr. McGuire was the Senior Vice President of Scientific Affairs for Enzon, Incorporated. He also served as Vice President for Research & Development and Chief Scientific Officer, and as Director of Business Development at Enzon.

“We were fortunate to get someone with Jeff’s expertise to join our efforts in positioning West as a leading drug delivery company”, said Bruce S. Morra, Ph.D., President of West’s Drug Delivery Systems Division. “Jeff will focus on finding appropriate partners to commercialize the innovative nasally and orally delivered products currently being developed at West, as well as identify opportunities where West’s unique skills can add significant value to both conventional and biotech drugs of interest to our clients.”

Dr. McGuire earned a Ph.D. in Life Sciences from the University of Delaware and a B.S. in Biological Science from the Massachusetts Institute of Technology. He also completed postdoctoral research at Harvard Medical School.

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE